Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
---|
08/30/1988 | US4767742 Hirudin-PA and its derivatives, process for manufacturing these and the use of these substances |
08/30/1988 | US4767710 Cell lines for the production of monoclonal antibodies to human glycophorin A |
08/30/1988 | US4767709 Dna, proliferin, eucaryotic cell |
08/30/1988 | US4767623 Method of binding microflora and preparations therefor |
08/30/1988 | US4767622 Method and materials for development of immunological responses protective against malarial infection |
08/30/1988 | CA1241283A1 Process for separating animal cells from a liquid culture |
08/29/1988 | EP0249635A4 Word recognition in a speech recognition system using data reduced word templates. |
08/29/1988 | EP0207963A4 Monoclonal antibodies and antigen for human non-small cell lung carcinomas. |
08/25/1988 | WO1988006187A1 A process for enzymatic production production of dipeptides |
08/25/1988 | WO1988006186A2 cDNAs ENCODING SOMATOTROPIN, EXPRESSION VECTORS AND HOSTS |
08/25/1988 | WO1988006184A1 Viral antigen, process for its production, and application in diagnosis and therapy (vaccine) |
08/25/1988 | WO1988006161A1 Human interleukin-3 and muteins thereof |
08/25/1988 | WO1988006040A1 Monoclonal antibodies in vaccine formulations |
08/25/1988 | WO1988005993A2 Aminopeptidase for removing n-terminal methionine from proteins and proteins prepared therefrom |
08/24/1988 | EP0279669A2 Cell surface marker of human pancreatic carcinoma cells |
08/24/1988 | EP0279582A2 DNA sequences to target proteins to the mammary gland for efficient secretion |
08/24/1988 | EP0279460A1 Virus antigen, method for its preparation and its use in diagnosis and therapy (as a vaccine) |
08/24/1988 | EP0279459A2 DNA coding an anticoagulant polypeptide |
08/24/1988 | CN87105411A Prepn. method about t cell and b cell antigens of hepatitis b virus surface antigen |
08/23/1988 | US4766203 Insecticides |
08/23/1988 | US4766070 Fermentation process and substrate |
08/23/1988 | US4766069 Recombinant DNA which codes for interleukin-1 B |
08/23/1988 | US4766066 Genetic engineering |
08/23/1988 | CA1240940A1 A-factor and its processing signals |
08/23/1988 | CA1240939A1 Monoclonal antibodies to human immune interferon |
08/23/1988 | CA1240938A1 Hybrid cell lines producing monoclonal antibodies directed against treponema |
08/23/1988 | CA1240937A1 Monoclonal igm antibodies and method of preparation |
08/17/1988 | EP0278940A2 Hepatitis B virus surface antigens and hybrid antigens containing them |
08/17/1988 | EP0278787A1 A process for enzymatic production of dipeptides |
08/17/1988 | EP0278776A2 Methods and deoxyribonucleic acid for the preparation of tissue factor protein |
08/17/1988 | EP0278697A2 A system for release of proteins from microbe cells |
08/17/1988 | EP0278696A2 An arg-serpin human plasminogen activator inhibitor designated PAI-2 |
08/17/1988 | EP0278541A1 Antigenically active proteins and peptides, and transmissible gastro-enteritis virus TGEV vaccines |
08/17/1988 | EP0278487A2 Process for the inactivation of enveloped viri in protein preparations produced in vitro by means of a single cell |
08/17/1988 | EP0278355A2 Novel expression system |
08/17/1988 | EP0278340A2 Mycoplasma membrane antigens and their use |
08/17/1988 | EP0278190A1 Process for the enzymatic preparation of aspartam |
08/17/1988 | EP0278160A2 Human monoclonal anti cancer antibodies, hybridoma cell lines producing them and their uses |
08/17/1988 | EP0278148A2 Peptide composition and method for the detection of antibodies to HTLV-III |
08/17/1988 | EP0278112A2 Pancreatic secretory trypsin inhibitor and its variants produced by genetic engineering |
08/17/1988 | CN87108308A Polypeptides and production thereof |
08/17/1988 | CN87107275A Monoclonal antibody specific to neutrophils |
08/16/1988 | US4764502 Intragonadal regulatory protein |
08/16/1988 | US4764475 Pancreas dependant immunoassay for determining subpopulations of monoclonal antibodies to somatostatin. |
08/16/1988 | US4764460 Hybridization probe assays, nonstructural |
08/11/1988 | WO1988005826A1 Polypeptides with activity against gram-positive and gram-negative bacteria |
08/11/1988 | WO1988005825A1 A method for producing factor viii in high yield |
08/11/1988 | WO1988005824A1 Selection of monoclonal antibodies to viral glycoproteins |
08/11/1988 | WO1988005819A1 RECOMBINANT PLASMID DNA pPR-IFNbeta1-13, CODING FOR SYNTHESIS OF HUMAN FIBROBLAST beta1-INTERFERON, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IFNbeta1-13) AS PRODUCER OF HUMAN beta1-INTERFERON, CONTAINING IT |
08/11/1988 | WO1988005818A1 RECOMBINANT PLASMID DNA pPR-IL2-19, CODING FOR SYNTHESIS OF HUMAN INTERLEUKIN-2, METHOD OF ITS CONSTRUCTION AND STRAIN OF BACTERIA ESCHERICHIA COLI VNIIGENETIKA VL 903 (pPR-IL2-19) AS PRODUCER OF HUMAN INTERLEUKIN-2, CONTAINING IT |
08/11/1988 | WO1988005816A1 Polypeptide |
08/11/1988 | WO1988005789A1 Isolation of single chain proteins with fsh suppressing activity from follicular fluid |
08/11/1988 | WO1988005788A1 Tranforming growth factor-beta |
08/11/1988 | WO1988005786A1 Colony stimulating factors having reduced levels of carbohydrate |
08/11/1988 | WO1988005785A1 Molecules comprising at least one peptidic sequence carrying one or a plurality of epitopes characterizing a protein produced by p. falciparum in hepatocytes and compositions containing them |
08/11/1988 | WO1988005783A1 Immunosuppressive peptides and methods of use |
08/11/1988 | WO1988005659A1 Human proteins having anticoagulant and anti-inflammatory activity |
08/11/1988 | WO1988003807A3 Production and use of a novel t-cell suppressor factor |
08/10/1988 | EP0277770A1 Alpha-mating factor promoter is modified by deleting pre-pro secretory leader sequence |
08/10/1988 | EP0277563A1 Polypeptide and production thereof |
08/10/1988 | EP0277540A1 Method for the determination of lysozyme activity |
08/10/1988 | EP0277313A1 Hybrid plasminogen activators |
08/10/1988 | EP0277212A1 Diagnostic assay for inhibitor of tissue-type and urokinase-type plasminogen activators, and gene coding for the inhibitor. |
08/10/1988 | EP0135532B1 Method of producing and selectively isolating proteins and polypeptides, recombinant and expression vector therefor and fusion protein able to bind to the constant region of immunoglobulins |
08/10/1988 | CN88100542A Precursor protein of apc polypeptide, dna coding for this, and diagnostic use of dna and of protein |
08/09/1988 | US4762791 Human immune interferon |
08/09/1988 | US4762784 Fermemtation process for the high level production of bovine growth hormone |
08/09/1988 | US4762783 Process and reagent for the determination of the follicle-stimulating hormone and monoclonal antibodies suitable therefor |
08/09/1988 | US4762708 Materials and methods for herpes simplex virus vaccination |
08/09/1988 | CA1240266A1 Method for purification of hbs antigen |
08/09/1988 | CA1240265A1 Lyophilized hepatitis b vaccine |
08/03/1988 | EP0277071A2 Process for the production of a human monoclonal antibody (IgG) anti-cytomegalovirus, and monoclonal antibody so obtained |
08/03/1988 | EP0277043A2 Method for recovering somatotropins from dilute aqueous solution |
08/03/1988 | EP0276846A2 Colony-stimulating factor derivatives |
08/03/1988 | EP0276723A2 Precursor protein of APC polypeptide, DNA coding therefor and diagnostic use of the DNA and protein |
08/03/1988 | EP0276591A2 Vaccine consisting of a viral vector and recombinant DNA coding for the p25 protein of the AIDS virus |
08/03/1988 | EP0276330A1 Recombinant plasmid dnas, coding for synthesis of polypeptide substances for a vaccine against hepatitis a |
08/03/1988 | CN86106574A Human insulin analogues |
08/02/1988 | US4761377 Human-human hybrid cell lines that produce antibodies against antigenic determinants on cancer cells |
08/02/1988 | US4761371 Genetic engineering |
08/02/1988 | CA1239871A1 Homogeneous human interleukin 2 and process thereof |
07/28/1988 | WO1988005469A1 Human interleukin-3 proteins |
07/28/1988 | WO1988005465A1 Production of fibroblast growth factor |
07/28/1988 | WO1988005440A1 Peptides having immunological properties 2-hiv-2 |
07/28/1988 | WO1988005309A1 Potentiation of cytotoxic conjugates |
07/28/1988 | WO1988003173A3 New forms of colony stimulating factor-1 |
07/27/1988 | EP0276008A2 Fibrin-specific antibody, method for its production and its use |
07/27/1988 | EP0275705A2 Monoclonal antibodies specific for human basal cells, SCC and precancerous cells |
07/27/1988 | EP0275689A1 Modified pertussis exotoxin |
07/27/1988 | EP0275606A1 Hybrid plasminogen activators with improved thrombolytic properties and drugs comprising these plasminogen activators |
07/27/1988 | EP0275305A1 Dna sequences coding for modified factor viii:c and modified factor viii:c-like polypeptides and processes for producing these polypeptides in high yields |
07/27/1988 | EP0275282A1 Process for purifying a plasminogen activator |
07/27/1988 | EP0275278A1 Peptide fragments of organ-specific neoantigens |
07/26/1988 | US4760156 Platinum co-ordination compounds |
07/26/1988 | US4760155 Platinum co-ordination compounds |
07/26/1988 | US4760026 Monoclonal antibody |
07/26/1988 | US4760023 Complimentary strand of polydeoxyribonucleotide |
07/26/1988 | US4760022 Stabilized plasmids |
07/20/1988 | EP0275204A2 Production of fibroblast growth factor |
07/20/1988 | EP0274946A1 Process for manufacturing an enzymatic protein hydrolysate rich in di- and tripeptides, for use in particular in artificial nutrition and in dietetics |